FIELD: veterinary medicine.
SUBSTANCE: invention relates to veterinary medicine and comprise a method of prevention mastitis of lactating cows, including the use of an immunomodulator, characterized in that bovine recombinant is used as an immunomodulator α- and γ-interferons, which are administered twice every month, from the first day after calving, intramuscularly in a dose of 2.5 ml with an interval of 24 hours.
EFFECT: invention provides an increasing effectiveness of the prevention of subclinical mastitis of cows.
1 cl, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTING MASTITIS IN LACTATING COWS | 2019 |
|
RU2731476C1 |
| PREVENTION OF MASTITIS IN LACTATING COWS | 2023 |
|
RU2804852C1 |
| METHOD OF TREATING SUBCLINICAL MASTITIS IN LACTATING COWS | 2021 |
|
RU2768609C1 |
| METHOD OF TREATMENT OF SUBCLINICAL MASTITIS IN LACTATING COWS | 2016 |
|
RU2619862C1 |
| METHOD FOR THE TREATMENT OF SUBCLINICAL MASTITIS IN LACTATING COWS | 2022 |
|
RU2783249C1 |
| METHOD OF THE PREVENTION OF ENDOMETRITIS AND MASTITIS IN COWS IN THE POSTPARTUM PERIOD | 2022 |
|
RU2798063C1 |
| TREATMENT OF MASTITIS IN LACTATING COWS | 2022 |
|
RU2796986C1 |
| METHOD FOR COMPLEX THERAPY OF MASTITIS IN LACTATING COWS | 2020 |
|
RU2756125C1 |
| METHOD FOR THE TREATMENT OF ACUTE POSTPARTUM ENDOMETRITIS IN COWS | 2020 |
|
RU2746297C1 |
| METHOD FOR PREVENTION OF SUBCLINICAL AND CLINICAL MASTITIS IN COWS | 2016 |
|
RU2605623C1 |
